Integral Diagnostics (ASX:IDX) - Aandelenkoers, Nieuws & Analyse

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

IDX Overzicht aandelen

IDX fundamentele analyse
Sneeuwvlok Score
Waardering	2/6
Toekomstige groei	4/6
Prestaties in het verleden	0/6
Financiële gezondheid	2/6
Dividenden	1/6

Beloningen

Verhandeld tegen 83.7% onder onze schatting van de reële waarde

De winst zal naar verwachting met 76.84% per jaar groeien

Risicoanalyse

Rentebetalingen worden niet goed gedekt door de winsten

Integral Diagnostics Limited Concurrenten

Australian Clinical Labs

ASX:ACL

AU$748.9m

Capitol Health

ASX:CAJ

AU$394.3m

Healius

ASX:HLS

AU$1.3b

Healthia

ASX:HLA

AU$252.1m

Prijsgeschiedenis en prestaties

Overzicht van alle hoogtepunten, veranderingen en prijsdalingen voor Integral Diagnostics
Historische aandelenkoersen
Huidige aandelenkoers	AU$3.02
52 Week Hoogtepunt	AU$3.06
52 Week Laag	AU$1.64
Bèta	0.73
11 maand verandering	16.60%
3 maanden verandering	15.71%
1 Jaar Verandering	9.42%
33 jaar verandering	-38.11%
5 jaar verandering	-3.51%
Verandering sinds IPO	65.03%

Recent nieuws en updates

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21

Recent updates

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Feb 21

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Nov 22

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

Feb 20

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Dec 14

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

May 26

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Feb 28

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

Feb 25

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Oct 29

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Sep 13

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Jun 04

Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?

May 14

Is Integral Diagnostics Limited (ASX:IDX) A Smart Choice For Dividend Investors?

May 03

We Think Integral Diagnostics (ASX:IDX) Can Stay On Top Of Its Debt

Apr 16

Is It Too Late To Consider Buying Integral Diagnostics Limited (ASX:IDX)?

Mar 27

Is Integral Diagnostics Limited's (ASX:IDX) Stock's Recent Performance A Reflection Of Its Financial Health?

Mar 17

Integral Diagnostics Limited's (ASX:IDX) Intrinsic Value Is Potentially 46% Above Its Share Price

Feb 03

Here's What We Learned About The CEO Pay At Integral Diagnostics Limited (ASX:IDX)

Jan 24

Should You Use Integral Diagnostics's (ASX:IDX) Statutory Earnings To Analyse It?

Jan 14

Shareholders Of Integral Diagnostics (ASX:IDX) Must Be Happy With Their 201% Total Return

Jan 05

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Dec 26

At AU$4.30, Is It Time To Put Integral Diagnostics Limited (ASX:IDX) On Your Watch List?

Dec 17

What To Know Before Buying Integral Diagnostics Limited (ASX:IDX) For Its Dividend

Dec 08

Returns On Capital At Integral Diagnostics (ASX:IDX) Paint An Interesting Picture

Nov 29

Is Integral Diagnostics Limited's (ASX:IDX) Shareholder Ownership Skewed Towards Insiders?

Nov 19

Is Integral Diagnostics (ASX:IDX) A Risky Investment?

Sep 20

Rendement voor aandeelhouders

	IDX	AU Healthcare	AU Markt
7D	1.7%	3.8%	1.1%
1Y	9.4%	-0.7%	17.9%

Rendement versus industrie: IDX overtrof de Australian Healthcare industrie, die het afgelopen jaar een rendement -0.7 % opleverde.

Rendement versus markt: IDX presteerde slechter dan Australian Market, dat het afgelopen jaar een rendement van 17.9 % opleverde.

Prijsvolatiliteit

Is IDX's price volatile compared to industry and market?
IDX volatility
IDX Average Weekly Movement	3.4%
Healthcare Industry Average Movement	5.1%
Market Average Movement	9.0%
10% most volatile stocks in AU Market	17.6%
10% least volatile stocks in AU Market	3.6%

Stabiele aandelenkoers: IDX heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.

Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 3% ) van IDX is het afgelopen jaar stabiel geweest.

Over het bedrijf

Opgericht	Werknemers	CEO	Website
1967	1,977	Ian Kadish	www.integraldiagnostics.com.au

Integral Diagnostics Limited, een bedrijf dat diensten verleent op het gebied van gezondheidszorg, houdt zich bezig met het leveren van diagnostische beeldvormingsdiensten aan huisartsen, medische specialisten en professionals in de gezondheidszorg en hun patiënten in Australië en Nieuw-Zeeland. Het bedrijf levert positronemissietomografie, magnetische resonantiebeeldvorming en andere radiologiediensten. Het bedrijf is opgericht in 1967 en heeft zijn hoofdkantoor in Melbourne, Australië.

Integral Diagnostics Limited Samenvatting

Hoe verhouden de winst en inkomsten van Integral Diagnostics zich tot de beurswaarde?
IDX fundamentele statistieken
Marktkapitalisatie	AU$706.43m
Inkomsten(TTM)	-AU$60.70m
Inkomsten(TTM)	AU$469.70m

1.5x

P/S-verhouding

-11.6x

Koers/Winstverhouding

Is IDX overgewaardeerd?

Zie Reële waarde en waarderingsanalyse

Inkomsten en omzet

Belangrijkste winstgevendheidsstatistieken uit het laatste winstverslag (TTM)
IDX resultatenrekening (TTM)
Inkomsten	AU$469.70m
Kosten van inkomsten	AU$317.80m
Brutowinst	AU$151.90m
Overige uitgaven	AU$212.60m
Inkomsten	-AU$60.70m

Laatst gerapporteerde inkomsten

Jun 30, 2024

Volgende inkomensdatum

n.v.t.

Winst per aandeel (EPS)	-0.26
Brutomarge	32.34%
Nettowinstmarge	-12.92%
Schuld/Eigen Vermogen Verhouding	72.8%

Hoe presteerde IDX op de lange termijn?

Bekijk historische prestaties en vergelijking

Dividenden

1.9%

Huidig dividendrendement

-22%

Uitbetalingsratio

IDX Overzicht aandelen

Beloningen

Risicoanalyse

Integral Diagnostics Limited Concurrenten

ASX:ACL

AU$748.9m

ASX:CAJ

AU$394.3m

ASX:HLS

AU$1.3b

ASX:HLA

AU$252.1m

Prijsgeschiedenis en prestaties

Recent nieuws en updates

Price target increased by 7.7% to AU$2.93

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

First half dividend of AU$0.025 announced

First half 2024 earnings: EPS misses analyst expectations

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Recent updates

Price target increased by 7.7% to AU$2.93

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Capitol Health Limited (ASX:CAJ) for approximately AUD 350 million.

First half dividend of AU$0.025 announced

First half 2024 earnings: EPS misses analyst expectations

Some Investors May Be Worried About Integral Diagnostics' (ASX:IDX) Returns On Capital

Consensus EPS estimates fall by 12%

IDX™ Announces Appointment of Scott Paterson as Worldwide CFO

Integral Diagnostics Limited, Annual General Meeting, Nov 01, 2024

Integral Diagnostics Limited Announces Change of Company Secretary

Independent Non-Executive Director recently bought AU$258k worth of stock

Integral Diagnostics Limited Announces Resignation of Helen Kurincic as Director Effective 29 November 2023

Consensus EPS estimates fall by 11%

Shareholders Will Probably Hold Off On Increasing Integral Diagnostics Limited's (ASX:IDX) CEO Compensation For The Time Being

Price target decreased by 7.5% to AU$3.05

Consensus EPS estimates fall by 10%

Investor sentiment deteriorates as stock falls 27%

Integral Diagnostics Limited Appoints Toby Hall as Director

Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Six Months Ended June 30, 2023, Payable on October 04, 2023

Full year 2023 earnings: EPS misses analyst expectations

Integral Diagnostics Limited Declares Fully Franked Final Dividend, Payable on October 04, 2023

Consensus EPS estimates fall by 16%

Integral Diagnostics Limited Announces Board Changes

Investor sentiment deteriorates as stock falls 18%

Integral Diagnostics' (ASX:IDX) Shareholders Will Receive A Smaller Dividend Than Last Year

First half 2023 earnings released: EPS: AU$0.069 (vs AU$0.051 in 1H 2022)

Integral Diagnostics Limited Announces Ordinary Dividend for the Six Months Ended December 31, 2022, Payable on April 4, 2023

Now 21% undervalued after recent price drop

Integral Diagnostics Limited to Report First Half, 2023 Results on Feb 17, 2023

Integral Diagnostics Limited to Report Fiscal Year 2023 Results on Aug 28, 2023

These 4 Measures Indicate That Integral Diagnostics (ASX:IDX) Is Using Debt Extensively

Independent Non-Executive Director recently bought AU$114k worth of stock

Consensus forecasts updated

Now 22% undervalued after recent price drop

Integral Diagnostics Limited Declares Fully Franked Final Dividend for the Year Ended June 30, 2022, Payable on October 5, 2022

Full year 2022 earnings released

Investor sentiment improved over the past week

Consensus forecasts updated

Price target decreased to AU$3.65

Integral Diagnostics Limited Announces Appointment of Andrew Fay as an Independent Non-Executive Director

Healius Reportedly Keeps Watching Brief on Integral Diagnostics

Should You Think About Buying Integral Diagnostics Limited (ASX:IDX) Now?

Now 21% undervalued after recent price drop

Integral Diagnostics Limited (ASX:IDX) ) agreed to acquire Exact Radiology Pty Ltd for NZD 33.3 million.

Integral Diagnostics Limited (ASX:IDX) agreed to acquire Exact Radiology Pty Ltd for approximately AUD 39 million.

Now 21% undervalued

Executive Director recently bought AU$70k worth of stock

Consensus forecasts updated

Integral Diagnostics (ASX:IDX) Is Paying Out Less In Dividends Than Last Year

Integral Diagnostics Limited (ASX:IDX) Shares Could Be 38% Below Their Intrinsic Value Estimate

First half 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Integral Diagnostics Limited Announces the Distribution for the Six Months Ended December 31, 2021, Payable on April 4, 2022

Consensus forecasts updated

Shareholders Would Not Be Objecting To Integral Diagnostics Limited's (ASX:IDX) CEO Compensation And Here's Why

Does Integral Diagnostics (ASX:IDX) Deserve A Spot On Your Watchlist?

Investor sentiment deteriorated over the past week

Full year 2021 earnings released: EPS AU$0.16 (vs AU$0.12 in FY 2020)

An Intrinsic Calculation For Integral Diagnostics Limited (ASX:IDX) Suggests It's 22% Undervalued

Should You Be Adding Integral Diagnostics (ASX:IDX) To Your Watchlist Today?